Research Article
The Impact of Vitamin D Deficiency on Retinopathy and Hearing Loss among Type 2 Diabetic Patients
Table 2
Clinical biochemistry baseline value among retinopathy hearing loss and normal hearing subject among T2DM patients (N = 638).
| Variables | Retinopathy with Hearing Loss ≥26 dB n=126 Mean ± SD | Non-Retinopathy Normal Hearing with diabetic <26 dB N = 512 Mean ± SD | P value |
| Vitamin D (ng/ml) | 19.40±9.71 | 22.67±9.28 | <0.001 | Hemoglobin (g/dL) | 12.85± 2.40 | 12.98±2.35 | 0.285 | Magnesium (mmol/L) | 0.76±0.10 | 0.90±0.09 | <0.001 | Potassium (mmol/L) | 4.49±0.45 | 4.48±0.38 | 0.830 | Calcium (mmol/L) | 2.18±0.38 | 2.39±0.26 | 0.036 | Phosphorous (mmol/L) | 1.40±0.32 | 1.58±0.29 | <0.001 | Creatinine (mmol/L) | 68.74±14.47 | 66.69±17.81 | 0.231 | Fasting Blood Glucose(mmol/L) | 7.50.13±1.30 | 7.33±1.01 | 0.041 | HbA1c | 8.35±1.04 | 7.60±1.01 | <0.001 | Cholesterol (mmol/L) | 3.40±0.66 | 3.16±0.80 | 0.002 | HDL-C (mmol/L) | 1.45±0.90 | 1.22±0.37 | 0.001 | LDL-C (mmol/L) | 1.97±0.92 | 1.72±0.69 | 0.025 | Albumin (mmol/L) | 40.10±4.41 | 38.68±4.09 | 0.001 | Bilirubin (mmol/L) | 7.10±1.46 | 6.12±1.64 | 0.001 | Triglyceride (mmol/L) | 1.82±0.87 | 1.72±2.58 | 0.110 | Uric Acid (mmol/L) | 275.8±99.8 | 287.9±89.51 | 0.272 | Systolic Blood Pressure mm Hg | 131.7±9.25 | 127.73±11.98 | 0.001 | Diastolic Blood Pressure mm Hg | 82.20±8.60 | 79.80±8.20 | 0.004 | Microalbuminuria | 14.59±2.49 | 9.07±3.50 | <0.001 |
| | n() | n() | |
| Vitamin D Level | | | | Deficiency 25(OH)D <20 ng/ml | 68(54.0) | 212(41.4) | | Insufficiency 25(OH)D 20-29 ng/ml | 38(30.2) | 183(35.7) | 0.004 | Optimal 25(OH)D 30-80 ng/ml | 20(15.8) | 117(22.9) | | Retinopathy | | | | Present | 24(19.0) | 52(10.2) | | Absent | 102(81.0) | 460(89.8) | 0.006 | Visual impairment level | | | | None | 102(81.0) | 460(89.8) | | Mild | 9(7.1) | 28(5.5) | 0.007 | Moderate or more | 15(11.9) | 24(4.7) | |
|
|